El-ASSAL, M.I. and SAMUEL, D. 2022. OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. International Journal of Pharmacy and Pharmaceutical Sciences. 14, 1 (Jan. 2022), 17–27. DOI:https://doi.org/10.22159/ijpps.2022v14i1.43145.